Latest EMA’s updates on the use of RWE in regulatory decision-making

The third annual report on the integration of real-world evidence (RWE) into regulatory decision-making shows a marked increase in the number of RWE studies conducted by the three pathways for generating RWE, the European consortium DARWIN EU, the framework contract (FWC), and in-house EMA studies. The PRAC Committee gave rise to the higher number of requests in the monitored period

The proposal of a Critical Medicines Act

The Critical Medicines Act proposed by the European Commission aims to overcome supply issues and shortages of medicinal products by mean of the activation of Strategic Projects, new procurement requirements and improved international partnerships

EIPG Meeting in Rome in April

By Piero Iamartino The 2024 General Assembly of EIPG (European Industrial Pharmacists Group) was held in Rome on…